Douglas Rosenberg (born December 12, 1957) is a business leader based in the San Francisco Bay Area.

Rosenberg is an active investor and entrepreneur involved in a broad range of businesses. Most notable is Royal Emerald Pharmaceuticals, a disabled veteran-owned company dedicated to creating compounds and formulations that address conditions like PTSD, opioid addiction, pain, and anxiety, to name a few. From October 2014 to September 2017, Rosenberg was chairman of Midwestern Bio Ag based in Madison, Wisconsin. He led successful capital campaigns to support the company’s ambitious growth plans.

Rosenberg founded and actively managed the Rosenberg Alzheimer's Project from 2007 to 2014. He began focusing on Alzheimer's disease as his father and step-parents died from complications of the disease. Frustrated by research and development proposals that began to sound familiar, he[1] embraced an outsider approach, looking for the most credible scientists with alternative views of the disease.[2]

Past grants supported the work of scientists pursuing novel therapies and those working to reduce the cost and time involved in developing potential cures. In early 2011, the Project[3] invested $3.5 million in the Buck Institute for Research on Aging, partnering with Dale Bredesen to examine alternative compounds to treat Alzheimer's disease.[4][5]

He holds a political science degree from Lewis & Clark College. He lives in Marin County.[6]

References

  1. ↑ "Developer Rosenberg steps up his Alzheimer's fight - San Francisco Business Times". Archived from the original on 2013-11-10.
  2. ↑ "Developer Rosenberg steps up his Alzheimer's fight - San Francisco Business Times". Bizjournals.com. 2012-08-17. Retrieved 2013-12-03.
  3. ↑ "Douglas Rosenberg invests $3.5M in Buck Institute to develop Alzheimer's drugs - San Francisco Business Times". Archived from the original on 2013-11-10.
  4. ↑ "Douglas Rosenberg invests $3.5M in Buck Institute to develop Alzheimer's drugs - San Francisco Business Times". Bizjournals.com. 2011-01-31. Retrieved 2013-12-03.
  5. ↑ "Donor Appreciation: Douglas Rosenberg | The Buck Institute for Research on Aging". Buckinstitute.org. Retrieved 2013-12-03.
  6. ↑ Kentfield resident to raise $10 million to aid Buck Institute's quest for Alzheimer's cureRetrieved 2016-12-17. Archived 2016-12-20 at the Wayback Machine
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.